Restoring melancholia in the classification of mood disorders

Journal of Affective Disorders

Volumn 105, Issue 1-3, 2008, Pages 1-14

  Taylor, Michael Alan ^a,b   Fink, Max ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Classification; Diagnosis; Major depression; Melancholia

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DEXAMETHASONE; FLUOXETINE; IMIPRAMINE; LITHIUM; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; LABORATORY TEST; MELANCHOLIA; MOOD DISORDER; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REM SLEEP; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; ELECTROCONVULSIVE THERAPY; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; PROGNOSIS;

EID: 36849006375     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.05.023     Document Type: Review

References (164)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., Perlman S.B., Turski P.A., Krahn D.D., Benca R.M., and Davidson R.J. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuro Report 9 (1998) 3301-3307
2. Abrams R. Electroconvulsive therapy. 4th ed (2002), Oxford University Press, New York
3. Akhondzadeh S., Faraji H., Sadeghi M., Afkham K., Fakhrzadeh H., and Kamalipour A. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. J. Clin. Pharm. Ther. 28 (2003) 379-384
4. Alvarez E., Perez-Sola V., Perez-Blanco J., Queralto J.M., Torrubia R., and Noguera R. Predicting outcome of lithium added to antidepressants in resistant depression. J. Affect. Disord. 42 (1997) 179-186
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition (1994), American Psychiatric Association, Washington D.C.
6. Anderson I.M. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J. Affect. Disord. 58 (2000) 19-36
7. Anderson I.M., and Tomenson B.M. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J. Psychopharmacol. 8 (1994) 238-249
8. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160 (1999) 1-12
9. Ayuso-Mateos J.L., Vazquez-Barquero J.L., Dowrick C., Lehtinen V., Dalgard O.S., Casey P., Wilkinson C., Lasa L., Page H., Dunn G., Wilkinson G., and ODIN Group. Depressive disorders in Europe: prevalence figures from the ODIN study. Br. J. Psychiatry 179 (2001) 308-316
10. Baethge C., Salvatore P., and Baldessarini R.J. Cyclothymia, a circular mood disorder. Hist. Psychiatr. 14 (2003) 377-399
11. Bagby R.M., Ryder A.G., and Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression. J. Psychiatry Neurosci. 27 (2002) 250-257
12. Baldessarini R.J., and Tondo L. Suicide risk and treatments for patients with bipolar disorder. JAMA 290 (2003) 1517-1519
13. Barbui C., and Hotopf M. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomized controlled trials. Br. J. Psychiatry 178 (2001) 129-144
14. Bauer M., and Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol. 19 (1999) 427-434
15. Benca R.M., Obermeyer W.H., Thisted R.A., and Gillin J.C. Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiatry 49 (1992) 651-668
16. Benazzi F. Psychomotor changes in melancholic and atypical depression: unipolar and bipolar II subtypes. Psychiatry Res. 112 (2002) 211-220
17. Bertelsen A., Harvald B., and Hauge M. A Danish twin study of manic-depressive disorders. Br. J. Psychiatry 130 (1977) 330-351
18. Biver F., Goldman S., Delvenne V., Luxen A., De Maertelaer V., Hubain P., Mendelwicz J., and Lostra F. Frontal and parietal metabolic disturbances in unipolar depression. Biol. Psychiatry 36 (1994) 381-388
19. Blazer D., Swartz M., Woodbury M., Manton K.G., Hughes D., and George L.K. Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. Arch. Gen. Psychiatry 45 (1988) 1078-1084
20. Blazer D.G., Kessler R.L., McGonagle K.A., and Swartz M.S. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151 (1994) 979-986
21. Block M., Schwartzman Y., Bonne O., and Lerer B. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. J. Clin. Psychopharmacol. 17 (1977) 44-48
22. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., Bronen R.A., Krystal J.H., Duncan J., Rich D., Price L.H., Malison R., Dey H., Soufer R., and Charney D.S. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry 54 (1997) 364-374
23. Bremner J.D., Naraya M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 157 (2000) 115-118
24. Brody A.L., Saxena S., Mandelkern M.A., Fairbanks L.A., Ho M.L., and Baxter Jr. L.R. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry 50 (2001) 171-178
25. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., Phelps M.E., Huang S.C., Wu H.M., Ho M.L., Ho M.K., Au S.C., Maidment K., and Baxter Jr. L.R. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy. Arch. Gen. Psychiatry 58 (2000) 631-640
26. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., and Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol. Psychiatry 41 (1997) 15-22
27. Burgess S., Geddes J., Hawton K., Townsend E., Jamison K., and Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst. Rev. (2001) 1-44 [CD003013]
28. Burvill P.W. An appraisal of the NIMH Epidemiologic Catchment Area Program. Aust. N.Z.J. Psychiatry 21 (1987) 175-184
29. Carroll B.J., Curtis G.C., and Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch. Gen. Psychiatry 33 (1976) 1039-1044
30. Carroll B.J., Feinberg M., Greden J.F., Haskett R.F., James N.M., Steiner M., and Tarika J. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. J. Affect. Dis. (1980) 177-194
31. Cassano G.B., Rucci P., Frank E., Fagiolini A., Dell'Osso L., Shear M.K., and Kupfer D.J. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am. J. Psychiatry 161 (2004) 1264-1269
32. Cheetham S.C., Crompton M.R., Katone C.L., and Horton R.W. Brain 5-HT 1 binding sites in depressed suicides. Psychopharmacol 102 (1990) 544-548
33. Cipriani A., Barbui C., and Geddes J.R. Suicide, depression, and antidepressants. BMJ 330 (2005) 373-374
34. Coryell W., and Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry 158 (2001) 748-753
35. Coryell W., Winokur G., Shea T., Maser J.D., Endicott J., and Akiskal H.S. The long-term stability of depressive subtypes. Am. J. Psychiatry 151 (1994) 199-204
36. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicenter study. Psychopharmacology (Berl) 90 (1986) 131-138
37. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J. Affect. Disord. 18 (1990) 289-299
38. Danish University Antidepressant Group. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J. Affect. Disord. 28 (1993) 105-116
39. Danish University Antidepressant Group. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Clin. Pharmacol. Ther. 66 (1999) 152-165
40. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu. Rev. Med. 49 (1998) 341-361
41. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. In advancing from the ventral striatum to the extended amygdala: implications for neuropsychiatry and drug abuse. Ann. NY Acad. Sci., New York (1999) 614-637
42. Drevets W.C. Integration of structural and functional neuroimaging in depression research. In: Dougherty D., Rauch S., and Rosenbaum J. (Eds). Psychiatric Neuroimaging Strategies: Research and Clinical Applications (1999), American Psychiatric Press, Washington DC
43. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 126 (2000) 413-431
44. Drevets W.C., and Botteron K. Neuroimaging in psychiatry. In: Guze S.B. (Ed). Adult Psychiatry (1997), Mosby, St. Louis 53-81
45. Drevets W.C., Spitznagel E., and Raichle M.E. Functional anatomical differences between major depressive subtypes. J. Cerebral. Blood Flow Metab. 15 (1995) S93
46. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., and Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
47. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.G., Huang Y., Gautier C., and Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46 (1999) 1375-1387
48. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., and Raichle M.E. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71 (2002) 431-447
49. Duffy A., Grof P., Robertson C., and Alda M. The implications of genetic studies of major mood disorders in clinical practice. J. Clin. Psychiatry 61 (2000) 630-637
50. Eaton W.W., Holzer III C.E., Von Korff M., Anthony J.C., Helzer J.E., George L., Burnam A., Boyd J.H., Kessler L.G., and Locke B.Z. The design of the epidemiologic catchment area surveys. The control and measure of error. Arch. Gen. Psychiatry 41 (1984) 942-948
51. Eaton W.W., Kramer M., Anthony J.C., Dryman A., Shapiro S., and Locke B.Z. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta. Psychiatr. Scand. 79 (1989) 163-178
52. Fava M., Alpert J., Nierenberg A., Lagomasino I., Sanowalla S., Tedlow J., Worthington J., Bauer L., and Rosenbaum J.F. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders or non-responders to fluoxetine. J. Clin. Psychopharmacol. 22 (2002) 379-387
53. Fink M. Should the dexamethasone suppression test be resurrected?. Acta. Psychiatr. Scand. 112 (2005) 245-249
54. Fink M., and Taylor M.A. Catatonia: A Clinician's Guide to Diagnosis and Treatment (2003), Cambridge University Press, Cambridge UK
55. First M.B., and Zimmerman M. Including laboratory tests in DSM-V diagnostic criteria. Am. J. Psychiatry 163 (2006) 2041-2042
56. Freemantle N., Anderson I.M., and Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Br. J. Psychiatry 177 (2000) 292-302
57. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., Bottlender R., Schule C., Zwanzger P., Engel R.R., Rupprecht R., Bondy B., Reiser M., and Moller J.H. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch. Gen. Psychiatry 61 (2004) 177-183
58. Furukawa T., McGuire H., and Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 325 (2002) 991-995
59. Gloor P., Olivier A., Quesney L.F., Andermann F., and Horowitz S. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann. Neurol. 12 (1982) 129-144
60. Gonzalez A.M., Pascual J., Meana J.J., Barturen F., del Arco C., Pazos A., and Garcia-Sevilla J.A. Autoradiographic demonstration of increased alpha 2-adrenoceptor binding sites in the hippocampus and frontal cortex of depressed suicide victims. J. Neurochem. 63 (1994) 256-265
61. Goodman S.H., and Gotlib I.H. Risk for psychopathology in children of depressed mothers: a developmental model of understanding mechanisms of transmission. Psychol. Rev. 106 (1999) 458-490
62. Goodwin F.K., and Jamison K.R. Manic-depressive Illness (1990), Oxford University Press, New York
63. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. NY Acad. Sci. 697 (1993) 53-60
64. Harmon-Jones E., Abramson L.Y., Sigelman J., Bohlig A., Hogan M.E., and Harmon-Jones C. Proneness to hypomania/mania symptoms or depression symptoms and asymmetrical frontal cortical responses to an anger-evoking event. J. Pers. Soc. Psychol. 82 (2002) 610-618
65. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 (2001) 1023-1039
66. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., Kragh-Soerensen P., and The Danish University Antidepressant Group. Are gender differences important for the clinical effects of antidepressants?. Am. J. Psychiatry 160 (2003) 1643-1650
67. Hirayasu Y., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., Yurgelon-Todd D., Zarate C., Kikinis R., Jolesz F.A., and McCarley R.W. Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 156 (1999) 1091-1093
68. Hirshfeld-Becker D.R., Biederman J., Calltharp S., Rosenbaum E.D., Farao S.V., and Rosenbaum J.M. Behavioral inhibition and disinhibition as hypothesized precursors to psychopathology: implications for pediatric bipolar disorder. Biol. Psychiatry 53 (2003) 985-999
69. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62 (2001) 77-91
70. Huang Y.Y., Oquendo M.A., Friedman J.M., Greenhill L.L., Brodsky B., Malone K.M., Khait V., and Mann J.J. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 28 (2003) 163-169
71. Ingraham L.J., and Wender P.H. Risk for affective disorder and alcohol and other drug abuse in the relatives of affectively ill adoptees. J. Affect. Disord. 26 (1992) 45-52
72. Jones I., Kent L., and Craddock N. The genetics of affective disorders. In: McGuffin P., Owen M.J., and Gottesman I.I. (Eds). Psychiatric Genetics and Genomics (2002), Oxford University Press, Oxford, England
73. Joyce P.R., Mulder R.T., Luty S.E., McKenzie J.M., Sullivan P.F., Abbott R.M., and Stevens I.F. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response. Aust. NZ J. Psychiatry 36 (2002) 376-383
74. Khan A., Detke M., Khan S.R.F., and Mallinckrodt C. Placebo response and antidepressant clinical trial outcome. J. Nerv. Ment. Dis. 191 (2003) 211-218
75. Keck M.E., and Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22 (2001) 835-844
76. Kellner C.H., Knapp R.G., Petrides G., Rummans T.A., Husain M., Rasmussen K., Mueller M., Bernstein H.J., O'Connor K., Smith K., Biggs M., Bailine S.H., and Fink M. Continuation ECT versus pharmacotherapy for relapse prevention in major depression: a multi-site study from CORE. Arch. Gen. Psychiatry 63 (2006) 1337-1344
77. Kendell R.E. The Classification of Depressive Illness (1968), Oxford University Press, London
78. Kendell R.E. The classification of depressions: a review of contemporary confusion. Br. J. Psychiatry 129 (1976) 15-28
79. Kendler K.S., and Gardner C.O. Boundaries of major depression: an evaluation of DSM-IV criteria. Am. J. Psychiatry 155 (1998) 172-177
80. Kendler K.S., Eaves L.J., Walters E.E., Neale M.C., Heath A.C., and Kessler R.C. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch. Gen. Psychiatry 53 (1996) 391-399
81. Kendler K.S., Gardner C.O., Neale M.C., and Prescott C.A. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes?. Psychol. Med. 31 (2001) 605-616
82. Klein D.N., Lewinsohn P.M., Seeley J.R., and Rohde P. A family study of major depressive disorder in a community sample of adolescents. Arch. Gen. Psychiatry 589 (2001) 13-20
83. Kessing L.V. Endogenous, reactive and neurotic depression - diagnostic stability and long-term outcome. Psychopathology 37 (2004) 124-130
84. Kessler R.C. Epidemiology of women and depression. J. Affect. Disord. 74 (2003) 5-13
85. Koper J.W., Stolk R.P., de Lange P., Huizenga N.A.M., Olijn G.J., Pols H.A., Grobbee D.E., Karl M., de Jong F.H., Brinkmann A.O., and Lamberts S.W. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum. Genet. 99 (1997) 663-668
86. Kovacs M., Devlin B., Pollock M., Richards C., and Mukerji P. A controlled family history study of childhood-onset depressive disorder. Arch. Gen. Psychiatry 54 (1997) 613-623
87. Leckman J.F., Weissman M.M., Prusoff B.A., Caruso K.A., Merikangas K.R., Pauls D.L., and Kidd K.K. Subtypes of depression. Arch. Gen. Psychiatry 41 (1984) 845-852
88. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., and Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 223 (2003) 8788-8799
89. Lieb R., Isensee B., Hofler M., Pfister H., and Wittchen H.U. Parental major depression and the risk of depression and other mental disorders in offspring. A prospective-longitudinal community study. Arch. Gen. Psychiatry 59 (2002) 365-374
90. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of serotonin 1A, glucorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 43 (1998) 547-573
91. Maes M., Dierckx R., Meltzer H.Y., Ingels M., Schotte C., Vandewoude M., Calabrese J., and Cosyns P. Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings. Psychiatry Res. 50 (1993) 77-88
92. McGuffin P., and Katz R. The genetics of depression and manic-depressive disorder. Br. J. Psychiatry 155 (1989) 294-304
93. McGuffin P., Rijsdijk F., and Andrew M. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60 (2003) 497-502
94. Meijer O.C., and de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit. Rev. Neurobiol. 12 (1998) 1-20
95. Meyer S.E., Chrousos G.P., and Gold P.W. Major depression and the stress system: a life span perspective. Dev. Psychopath. 13 (2001) 565-580
96. Modell S., Lauer C.J., Schreiber W., Huber J., Krieg J.C., and Holsboer F. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familiar risk for affective disorder. Neuropsychopharmacology 18 (1998) 253-262
97. Moldin S.O., Reich T., and Rice J.P. Current perspectives on the genetics of unipolar depression. Behav. Genet. 21 (1991) 211-242
98. Navarro V., Gasto C., Torres X., Marcos T., and Pintor L. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatr. Scand. 103 (2001) 435-440
99. Navarro V., Gasto C., Lomena F., Mateos J.J., Marcos T., and Portella M.J. Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study. Neuroimage 16 (2002) 781-787
100. Navarro V., Gasto C., Lomena F., Mateos J.J., Portella M.J., Massana G., Bernardo M., and Marcos T. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study. J. Clin. Psychiatry 65 (2004) 656-661
101. Nelson J.C., and Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 154 (1997) 1497-1503
102. Neuman R., Geller B., Rice J.P., and Todd R. Increased prevalence and earlier onset of mood disorders among relatives of prepubertal versus adult probands. J. Am. Acad. Child Adolesc. Psych. 36 (1997) 466-473
103. Nobler M.S., and Roose S.P. Differential response to antidepressants in melancholic and severe depression. Psychiatr. Ann. 28 (1998) 84-88
104. Nobler M.S., Sackeim H.A., Prohovnik I., Moeller J.R., Mukherjee S., Schnur D.B., Prudic J., and Devanand D.P. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch. Gen. Psychiatry 51 (1994) 884-897
105. Nofzinger E.A., Keshavan M.S., Buysse D.J., Moore R.Y., Kupfer D.J., and Reynolds C.F. Neurobiology of sleep in relation to mental illness. In: Charney D.S., Nestler E.J., and Bunney B.S. (Eds). Neurobiology of Mental Illness (1999-1999), Oxford University Press, New York 915-929
106. Okun M.S., Green J., Saben R., Gross R., Foote K.D., and Vitek J.L. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1584-1586
107. Olsson G.I., and von Knorring A.L. Adolescent depression: prevalence in Swedish high-school students. Acta Psychiatr. Scand. 99 (1999) 324-331
108. Paradiso S., Lamberty G.J., Garvey M.J., and Robinson R.G. Cognitive impairment in the euthymic phase of chronic unipolar depression. J. Nerv. Ment. Dis. 185 (1997) 748-754
109. Parianti C.M., and Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49 (2001) 391-404
110. Parker G., and Hadzi-Pavlovic D. Melancholia: a disorder of movement and mood (1996), Cambridge University Press, Cambridge UK
111. Parra J., Augustijn P.B., Geerts Y., and Van Emde Boas W. Classification of epileptic seizures: a comparison of two systems. Epilepsia 42 (2001) 476-482
112. Paykel E.S. Classification of depressed patients: a cluster-analysis derived grouping. Br. J. Psychiatry 118 (1971) 275-288
113. Paykel E.S., Prusoff B.A., Klerman G.L., Haskell D., and di Mascio A. Clinical response to amitriptyline among depressed women. J. Nerv. Ment. Dis. 156 (1973) 149-165
114. Perry P.J. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J. Affect. Disord. 20 39 (1996) 1-396
115. Petrides G., Fink M., Husain M.M., Knapp R., Rush A.J., Mueller M., Rummans T.A., O'Connor K.M., Rasmussen K.G., Bernstein H.J., Biggs M., Bailine S.H., and Kellner C.H. ECT remission rates in psychotic versus non-psychotic depressed patients: a report from CORE. JECT 17 (2001) 244-253
116. Preskorn S.H., and Fast G.A. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J. Clin. Psychiatry 52 suppl (1991) 23-33
117. Preskorn S.H., and Burke M. Somatic therapy for major depressive disorder: selection of an antidepressant. J. Clin. Psychiatry 53 suppl (1992) 5-18
118. Price L.H., Nelson J.C., Charney D.S., and Quinlan D.M. Family history in delusional depression. J. Affect. Disord. 6 (1984) 109
119. Price L.H., Carpenter L.L., and Rasmussen S.A. Drug combination strategies. In: Amsterdam J.D., Hornig M., and Nierenberg A.A. (Eds). Treatment-Resistant Mood Disorders (2001), Cambridge University Press, Cambridge, UK 194-222
120. Prusoff B.A., and Paykel E.S. Typological prediction of response to amitriptyline: a replication study. Int. Pharmacopsychiatry 12 (1977) 153-159
121. Puig-Antich J., Goetz D., Davies M., Kaplan T., Davies S., Ostrow L., Asnis L., Twomey J., Lyengar S., and Ryan N.D. A controlled family history study of prepubertal major depressive disorder. Arch. Gen. Psychiatry 46 (1989) 406-418
122. Raadsheer F.C., Heerikuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., and Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 152 (1995) 1372-1376
123. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., and Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry 51 (1994) 62-70
124. Roose S.P., Glassman A.H., Attia E., and Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am. J. Psychiatry 151 (1994) 1735-1739
125. Rorsman B., Grasbeck A., Hagnell O., Lanke J., Ohman R., Ojesjo L., and Otterbeck L. A prospective study of first-incidence depression. The Lundby Study, 1957-72. Br. J. Psychiatry 156 (1990) 336-342
126. Rothschild A.J. The hypothalamic-pituitary-adrenal axis and psychiatric illness. In: Wolkowitz O.M., and Rothschild A.J. (Eds). Psychoneuroendocrinology: The Scientific Basis of Clinical Practice 6 (2003), American Psychiatric Publishing, Washington DC 139-163
127. Rubin E., Sackeim H.A., Nobler M.S., and Moeller J.R. Brain imaging studies of antidepressant treatments. Psychiatr Ann. 24 (1994) 653-658
128. Rush A.J., and Weissenburger J.E. Melancholic symptom features and DSM-IV. Am. J. Psychiatry 151 (1994) 489-498
129. Rush A.J., Giles D.E., Schlesser M.A., Orsulak P.J., Parker C.R., Weissenburger J.E., Crowley J.T., Khatami M., and Vasavada N. The dexamethasone suppression test in patients with mood disorders. J. Clin. Psychiatry 57 (1996) 470-484
130. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., Ritz L., Biggs M.M., Warden D., Luther J.F., Shores-Wilson K., Niederehe G., and Fava M. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 354 (2006) 1231-1242
131. Sackeim H.A., Haskett R.F., Mulsant B.H., Thase M.E., Mann J.J., Pettinati H.M., Greenberg R.M., Crowe R.R., Cooper T.R., and Prudic J. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 285 (2001) 1299-1307
132. Sanders A.R., Detera-Wadleigh S.D., and Gershon E.S. Molecular genetics of mood disorders. In: Charney D.S., Nestler E.J., and Bunney B.S. (Eds). Neurobiology of Mental Illness (1999), Oxford University Press, New York
133. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., and Cowen P.J. Brain serotonin 1A receptor finding measured by positron tomography with [11c]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57 (2000) 174-180
134. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., Huang S.C., Wu H.M., Au S.C., and Baxter Jr. L.R. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol. Psychiatry 50 (2001) 159-170
135. Saxena S., Brody A.L., Ho M.L., Alborzian S., Maidment K.M., Zohrabi N., Ho M.K., Huang S.C., Wu H.M., and Baxter Jr. L.R. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs. major depression. Arch. Gen. Psychiatry 59 (2002) 250-261
136. Schatzberg A.F. Noradrenergic versus serotonergic antidepressants: predictors of treatment response. J. Clin. Psychiatry 59 suppl 14 (1998) 15-18
137. Schneider F., Gur R.E., Mozley L.H., Smith R.J., Mozley P.D., Censits D.M., Alavi A., and Gur R.C. Mood effects on limbic blood flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res. 61 (1995) 265-283
138. Shah P.J., Ebmeier K.P., Glabus M.F., and Goodwin G.M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br. J. Psychiatry 172 (1998) 527-532
139. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. 93 (1996) 908-913
140. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160 (2003) 1515-1518
141. Silverman C. The epidemiology of depression. A review. Am. J. Psychiatry 124 (1968) 883-891
142. Sullivan P.F., Neale M.C., and Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157 (2001) 1552-1562
143. Sullivan P.F., Prescott C.A., and Kendler K.S. The subtypes of major depression in a twin registry. J. Affect. Disord. 68 (2002) 273-284
144. Taylor M.A., and Abrams R. Reassessing the bipolar-unipolar dichotomy. J. Affect. Disord. 2 (1980) 195-217
145. Taylor M.A., and Fink M. Melancholia: The Diagnosis, Pathophysiology, and Treatment of Depressive Illness (2006), Cambridge University Press, Cambridge UK
146. Taylor M.A., Abrams R., and Hayman M. The classification of affective disorder: A reassessment of the bipolar-unipolar dichotomy; Part 1: A clinical, laboratory and family study. J. Affect. Disord. 2 (1980) 95-109
147. Thase M.E. Effectiveness of antidepressants: comparative remission rates. J. Clin. Psychiatry 64 suppl 2 (2003) 3-7
148. Todd R.D., Neuman R., Geller B., Fox L.W., and Hickok J. Genetic studies of affective disorders: should we be starting with childhood onset probands?. J. Am. Acad. Child Adolesc. Psych. 32 (1993) 1164-1171
149. Torgersen S. Genetic factors in moderately severe and mild affective disorders. Arch. Gen. Psychiatry 43 (1986) 222
150. Tsuang M.T., and Faraone S.V. The Genetics of Mood Disorders (1990), Johns Hopkins University Press, Baltimore
151. Tsuang M.T., Faraone S.V., and Green R.R. Genetic epidemiology of mood disorders. In: Papolos D.F., and Lachman H.M. (Eds). Genetic Studies in Affective Disorders (1994), Wiley, New York
152. Van de Kar L.D., and Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front. Neuroendocrinol. 20 (1999) 1-48
153. Weissman M.M. Psychopathology in the children of depressed parents: direct interview studies. In: Dunner D.L., Gershon E.S., and Barrett J.B. (Eds). Relatives at Risk for Mental Disorder (1988), Raven Press, New York, NY 143-159
154. Weissman M.M., Gershon E.S., Kidd K.K., Prusoff B.A., Leckman J.F., Dibble E., Hamovit J., Thompson W.D., Pauls D.L., and Guroff J.J. Psychiatric disorders in the relatives of probands with affective disorder. Arch. Gen. Psychiatry 41 (1984) 13-21
155. Weissman M.M., Warner V., Wickramaratne P., and Prusoff B.A. Early-onset major depression in parents and their children. J. Affect. Disord. 15 (1988) 269-277
156. Williamson D.E., Birmaher B., Axelson D.A., Ryan N.D., and Dahl R.E. First episode of depression in children at low and high familial risk for depression. J. Am. Acad. Child Adolesc. Psych. 43 (2004) 291-297
157. Winokur G., and Coryell W. Familial subtypes of unipolar depression: a prospective study of familial pure depressive disease compared to depressive spectrum disease. Biol. Psychiatry 32 (1992) 1012-1018
158. Wu J.C., Gillin J.C., Buchsbaum M.S., Hershey T., Johnson J.C., and Bunney Jr. W.E. Effect of sleep deprivation on brain metabolism of depressed patients. Am. J. Psychiatry 149 (1992) 538-543
159. Yehuda R., Boisoneau D., Mason J.W., and Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders. Biol. Psychiatry 34 (1993) 18-25
160. Yerevanian B.I., Feusner J.D., Koek R.J., and Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J. Affect. Disord. 83 (2004) 103-108
161. Young M.A., Scheftner W.A., Klerman G.L., Andreasen N.C., and Hirschfeld R.M.A. The endogenous sub-type of depression: a study of its internal construct validity. Br. J. Psychiatry 148 (1986) 257-267
162. Young M.A., Keller M.B., Lavori P.W., Scheftner Wa., Fawcett Ja., Endicott J., and Hirschfeld R.M. Lack of stability of the RDC endogenous subtype in consecutive episodes of major depression. J. Affect. Disord. 12 (1987) 139-143
163. Young E.A., Haskett R.F., Murphy-Weinberg V., Watson S.J., and Akil H. Loss of glucocorticoid fast feedback in depression. Arch. Gen. Psychiatry 48 (1991) 693-699
164. Zimmerman M., Coryell W., Pfohl B., and Stangi D. The validity of four definitions of endogenous depression. Arch. Gen. Psychiatry 43 (1986) 234